Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 2 of 2 items.
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
AlertHealth professional risk communication | 2023-01-17